German biotech CatalYm cashes in on early-stage cancer data with $150M series D 0 12.07.2024 18:42 Fiercebiotech.com German biotech CatalYm cashes in on early-stage cancer data with $150M series D dincorvaia Fri, 07/12/2024 - 11:42
